Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in Orlando, Florida. The company will sponsor 22 e-posters – including two oral presentations – with updates on a number of its innovative products, including Nemluvio, Sculptra, Restylane and Relfydess. These presentations combined reinforce the strength of Galderma’s growth journey, its status as the pure-play category leader in dermatology, and its innovative pipeline.
|
First author |
Abstract title |
Presentation type |
|
Acne |
||
|
I. Berlin
|
Adult acne in association with sensitive skin: a worldwide profiling survey |
E-poster |
|
L. Kircik |
Cleanse, treat, moisturize, protect (CTMP®) regimen: enhancing skin quality and treatment outcomes in acne and sensitive skin |
E-poster |
|
Atopic dermatitis |
||
|
M. Zirwas |
Systemic treatment and healthcare resource utilization in US patients with atopic dermatitis across ethnic groups: a retrospective analysis of the US Medicaid database (2017-2022) |
Oral e-poster |
|
G. Yosipovitch |
Baseline itch severity and time to first initiation of therapy with a biologic in patients with moderate or severe atopic dermatitis: a Retrospective cohort study of a population treated between 2022 and 2024 in specialty dermatology practices across the US |
E-poster |
|
J. Silverberg |
Continuous response with nemolizumab up to 56 weeks during a long-term extension study in patients with moderate-to-severe atopic dermatitis and partial or delayed skin response at Week 16 – Post-hoc analyses from the pooled ARCADIA 1&2 trials and long-term extension study |
E-poster |
|
Prurigo nodularis |
||
|
S. Ständer |
Characterization of the pruriginous lesion types in individuals with prurigo nodularis and efficacy from the randomized, placebo-controlled Phase 3 OLYMPIA 1&2 trials |
Oral e-poster
Friday 7 Mar, 11:50 AM - 11:55 AM |
|
Toxins |
||
|
G. Ablon |
RelaBoNT-A treatment of glabellar lines and lateral canthal lines of different baseline severity: subgroup analyses of pooled Phase III study data |
E-poster |
|
J. Kaufman-Janette |
Aesthetic Improvement with liquid relabotulinum-A treatment in a 12-month randomized controlled trial among subjects with moderate-to-severe glabellar lines |
E-poster |
|
E. Lain |
READY-4: Long-term safety with repeated injections using RelabotulinumtoxinA, a novel liquid formulation botulinum toxin, in the treatment of glabellar and lateral canthal lines |
E-poster |
|
Hyaluronic Acid-fillers |
||
|
S. Weiner |
Split-face study of two hyaluronic acid fillers in midface rejuvenation: clinical implications |
E-poster |
|
A. Nikolis |
AI-enabled MAUDE database analysis of delayed complications with hyaluronic acid fillers reveals technology-based differences |
E-poster |
|
Poly-L-lactic Acid |
||
|
M. Somenek |
Synergistic efficacy and safety of Poly-L-Lactic acid biostimulator and hyaluronic acid filler for facial fullness post weight loss due to glucagon-like peptide-1 receptor agonist medication |
E-poster |
|
S. Shridharani |
Consensus and evidence-based recommendations on the impact of minimally invasive treatments on subsequent facial surgery for additional aesthetic enhancement |
E-poster |
|
O. Markowitz |
A comparative study evaluating the synergistic effects for midface improvement when pairing PLLA-SCA with a skincare regimen |
E-poster |
|
J. Waibel |
Comparative bulk RNA-seq analysis of poly-l-actic acid vs calcium hydroxylapatite reveals PLLA has an adipocyte mediated regenerative mechanism of action |
E-poster |
|
Skinbooster |
||
|
M. Morse |
Addressing an unmet need for sensitive skin: A formulation to enable daily exfoliation |
E-poster |
|
S. Anjuwon |
Clinical evaluation of a new dermo-cosmetic regimen to improve atopic dermatitis prone skin associated severity, itch and quality of life |
E-poster |
|
M. Clément |
Acne-prone with sensitive skin management in modern dermatology |
E-poster |
|
Sensitive Skin |
||
|
H. Thu |
Visual improvement of the skin after use of a ceramide serum and vitamin C serum |
E-poster |
|
A. Widgerow |
An innovative firming cream improves signs and symptoms of dermatoporosis in subjects aged 65 and over |
E-poster |
|
A. Widgerow |
Daily use of a novel firming cream improves thinning, pre-dermatoporosis skin |
E-poster |
|
D. Draelos |
Efficacy and tolerability of a sensitive skin cleansing and moisturizing regimen in patients with plaque psoriasis undergoing prescription treatment |
E-poster |